1-3 of 3
Brandon Lam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract

Open Access
Talia R. Henkle, Brandon Lam, Yu Jui Kung, John Lin, Ssu-Hsueh Tseng, Louise Ferrall, Deyin Xing, Chien-Fu Hung, T.-C. Wu
Journal: Cancer Research
Cancer Res (2021) 81 (17): 4560–4569.
https://doi.org/10.1158/0008-5472.CAN-21-0399
Published: 01 September 2021
View articletitled, Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
Open the PDF for Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract in another window
Includes: Supplementary data
Journal Articles

Abstract 2970: MEDI4276, a HER2-targeting antibody tubulysin conjugate, displays potent in vitro and in vivo activity in preclinical studies

Free
John Li, Dorin Toader, Samuel R. Perry, Vanessa Muniz-Medina, Leslie Wetzel, Marlon C. Rebelatto, Mary Jane Masson Hinrichs, Ryan Fleming, Binyam Bezabeh, Pamela Thompson, Nazzareno Dimasi, Brandon Lam, Xian-Qing Yu, Changshou Gao, Rakesh Dixit, Steven Coats, Jane Osbourn, Herren Wu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2970.
https://doi.org/10.1158/1538-7445.AM2016-2970
Published: 15 July 2016
View articletitled, Abstract 2970: MEDI4276, a HER2-targeting antibody tubulysin conjugate, displays potent in vitro and in vivo activity in preclinical studies
Journal Articles

Abstract #2803: In vivo pharmacology of MEDI-573, an anti-IGF-I and IGF-II antibody that targets the IGF-1R and IR-A signaling pathways

Free
Jin Gao, Jon Chesebrough, Brandon Lam, Cherryle Funelas, Bahija Jallal, Steven Coats, Mohammad Tabrizi, Yong Chang
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2803.
Published: 01 May 2009
View articletitled, Abstract #2803: In vivo pharmacology of MEDI-573, an anti-IGF-I and IGF-II antibody that targets the IGF-1R and IR-A signaling pathways